A Travis County family is racing to raise $3 million to develop a one-of-a-kind treatment for their baby, who has an ...

Patients with acid reflux, which occurs when stomach acid pushes up into the esophagus, know the symptoms all too well: ...

You're mid-meal at your favorite Mexican place when that dreaded heat starts to creep up your chest—and you have no antacids ...

"In his legacy and his honor, we’re trying our hardest to wipe this disease off the planet," Gilbert said Jesse D. Garrabrant/NBAE via Getty Cleveland Cavaliers owner Dan Gilbert is contributing about ...

WE all suffer a headache from time to time but there are some instances where it warrants a consultation with your doctor. Most often headaches are caused by a cold or flu, stress, drinking too ...

What if eyes could use light to heal themselves? Drawing inspiration from how plants harness sunlight, researchers at the National University of Singapore (NUS) are pioneering a revolutionary ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, according to findings from two new trials. “These ...

A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, according to findings from two new trials.

It will take the largest donors in America and help from Congress, but the American Center for Cures thinks it can rid the world of chronic and deadly diseases. Lou Weisbach is co-founder of the group ...

It's a running joke that a cure for type 1 diabetes is only five years away and has been for 50 years, but new stem cell trials and immune drugs hint that we're closer than ever to a functional cure ...

Every Cure is using AI to seek new uses for the roughly 4,000 existing drugs, and cutting traditional preliminary research timelines from as much as 100 days to as little as 17 hours. Treatment for a ...

Pfizer and Valenva are seeking regulatory approval from the Food and Drug Administration for a Lyme disease vaccine in development that's more than 70% effective against the tick-borne illness.